Muutke küpsiste eelistusi

E-raamat: Basic Urological Management

  • Formaat: EPUB+DRM
  • Ilmumisaeg: 02-Nov-2018
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783319987200
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 110,53 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 02-Nov-2018
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783319987200
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book describes basic urological conditions and their management, with flowcharts to illustrate each step of patient treatment. Topics related to the upper and lower tract, urological infections, trauma, incontinence, andrology, and uro-oncology are all covered. The management of each condition is explained through point by point analysis that details patient pathways.





Basic Urological Management aims to aid management decision making within urology and at specific points within patient pathways.
1 Visible Haematuria
1(6)
Suggested Reading
5(2)
2 Diagnostic Pathway for Haematuria
7(4)
Suggested Reading
10(1)
3 Non-Visible Haematuria
11(4)
Suggested Reading
13(2)
4 Management Pathway for Bladder Tumour
15(4)
Suggested Reading
17(2)
5 Elevated PSA/Abnormal DRE
19(4)
Suggested Reading
22(1)
6 Diagnostic Pathway for Prostate Cancer
23(2)
Suggested Reading
24(1)
7 Management Pathway for Prostate Cancer in Younger Patients
25(2)
Suggested Reading
26(1)
8 Management Pathway for Older Patients with Prostate Cancer
27(2)
Suggested Reading
27(2)
9 Management of TRUS Biopsy Sepsis
29(2)
Suggested Reading
30(1)
10 Haematospermia
31(4)
Suggested Reading
33(2)
11 Diagnostic and Management Pathway for Haematospermia
35(2)
Suggested Reading
35(2)
12 Lower Urinary Tract Symptoms
37(4)
Suggested Reading
39(2)
13 Diagnostic Pathway for LUTS
41(4)
Suggested Reading
43(2)
14 Management Pathway for LUTS-Benign Prostatic Enlargement
45(2)
Suggested Reading
45(2)
15 Acute Urinary Retention
47(4)
Suggested Reading
49(2)
16 Diagnostic Pathway for Acute Urinary Retention
51(2)
Suggested Reading
51(2)
17 Management Pathway for Acute Urinary Retention
53(2)
Suggested Reading
53(2)
18 Difficult Catheters
55(4)
Suggested Reading
57(2)
19 Management Pathway for Difficult Catheters
59(2)
Suggested Reading
59(2)
20 Chronic Retention
61(2)
Suggested Reading
62(1)
21 Diagnostic Pathway for Chronic Retention
63(2)
Suggested Reading
63(2)
22 Management Pathway for Chronic Retention
65(2)
Suggested Reading
65(2)
23 Metastatic Spinal Cord Compression
67(2)
Suggested Reading
68(1)
24 Diagnostic Pathway for Metastatic Spinal Cord Compression
69(2)
Suggested Reading
70(1)
25 Management Pathway for Metstatic Spinal Cord Compression
71(2)
Suggested Reading
71(2)
26 Urethral Strictures
73(2)
Suggested Reading
74(1)
27 Diagnostic Pathway for Urethral Strictures
75(4)
Suggested Reading
78(1)
28 Management of Urethral Strictures
79(2)
Suggested Reading
79(2)
29 Nocturnal Polyuria
81(2)
Suggested Reading
82(1)
30 Diagnostic Pathway for Nocturnal Polyuria
83(2)
Suggested Reading
83(2)
31 Management Pathway for Nocturnal Polyuria
85(2)
Suggested Reading
85(2)
32 Dysuria
87(4)
Suggested Reading
89(2)
33 Diagnostic Pathway for Dysuria
91(2)
Suggested Reading
91(2)
34 Management Pathways for Dysuria: Recurrent UTIS
93(2)
Suggested Reading
93(2)
35 Sepsis
95(4)
Suggested Reading
97(2)
36 Diagnostic and Management Pathway for Sepsis
99(2)
Suggested Reading
99(2)
37 Acute Pyelonephritis
101(4)
Suggested Reading
103(2)
38 Chronic Pyelonephritis
105(4)
Suggested Reading
107(2)
39 Diagnostic Pathway for Pyelonephritis
109(2)
Suggested Reading
110(1)
40 Management Pathway for Pyelonephritis
111(2)
Suggested Reading
111(2)
41 Cystitis
113(4)
Suggested Reading
115(2)
42 Diagnostic Pathway for Cystitis
117(2)
Suggested Reading
117(2)
43 Management Pathway for Cystitis
119(2)
Suggested Reading
119(2)
44 Pyonephrosis
121(4)
Suggested Reading
123(2)
45 Diagnosis of Pyonephrosis
125(2)
Suggested Reading
126(1)
46 Management Pathway for Pyonephrosis
127(2)
Suggested Reading
127(2)
47 Perinephric Abcess
129(4)
Suggested Reading
131(2)
48 Diagnostic Pathway for Perinephric Abcess
133(2)
Suggested Reading
134(1)
49 Management Pathway for Perinephric Abcess
135(2)
Suggested Reading
135(2)
50 Necrotising Fasciitis
137(4)
Suggested Reading
139(2)
51 Diagnostic Pathway for Necrotising Fasciitis
141(2)
Suggested Reading
142(1)
52 Management Pathway for Necrotising Fasciitis
143(2)
Suggested Reading
143(2)
53 Scrotal Abscess
145(2)
Suggested Reading
146(1)
54 Diagnostic Pathway for Scrotal Abcess
147(2)
Suggested Reading
147(2)
55 Management Pathway for Scrotal Abcess
149(2)
56 Epididymitis/Orchitis
151(4)
Suggested Reading
153(2)
57 Diagnostic Pathway for Epididymo-Orchitis
155(2)
Suggested Reading
155(2)
58 Management Pathway for Epididymo-Orchtis
157(2)
Suggested Reading
157(2)
59 Prostatitis
159(4)
Suggested Reading
161(2)
60 Diagnostic Pathway for Prostatitis
163(2)
Suggested Reading
164(1)
61 Management Pathway for Prostatitis
165(2)
Suggested Reading
165(2)
62 Renal/Ureteric Colic
167(4)
Suggested Reading
169(2)
63 Diagnostic Pathway for Stones
171(2)
Suggested Reading
172(1)
64 Management Pathway for Renal Stones
173(4)
Suggested Reading
176(1)
65 Management Pathway for Ureteric Stones
177(2)
Suggested Reading
178(1)
66 Ureteral Clot Colic
179(2)
Suggested Reading
180(1)
67 Diagnosis of Ureteral Clot Colic
181(2)
Suggested Reading
181(2)
68 Management of Ureteral Clot Colic
183(4)
Suggested Reading
185(2)
69 Pelvi-Ureteric Junction Obstruction
187(4)
Suggested Reading
189(2)
70 Diagnosis of PUJO
191(2)
Suggested Reading
191(2)
71 Management of PUJO
193(2)
Suggested Reading
193(2)
72 Hydronephrosis
195(2)
Suggested Reading
196(1)
73 Diagnosis of Hydronephrosis
197(4)
Suggested Reading
199(2)
74 Management of Hydronephrosis
201(4)
Suggested Reading
203(2)
75 Renal Trauma
205(4)
Suggested Reading
207(2)
76 Grading of Renal Trauma
209(4)
Suggested Reading
211(2)
77 Diagnostic Pathway for Renal Trauma
213(2)
Suggested Reading
213(2)
78 Management Pathway for Renal Trauma
215(2)
Suggested Reading
216(1)
79 Ureteric Trauma
217(4)
Suggested Reading
219(2)
80 Ureteric Injury Severity Scale
221(2)
Suggested Reading
222(1)
81 Diagnostic Pathway for Ureteric Trauma
223(2)
Suggested Reading
224(1)
82 Management of Ureteric Injury
225(2)
Suggested Reading
226(1)
83 Bladder Trauma
227(4)
Suggested Reading
229(2)
84 Injury Severity Scale, Bladder Trauma
231(2)
Suggested Reading
231(2)
85 Diagnosis of Bladder Trauma
233(2)
Suggested Reading
234(1)
86 Management of Bladder Trauma
235(2)
Suggested Reading
236(1)
87 Urethral Trauma
237(4)
Suggested Reading
240(1)
88 Urethral Injury Severity Scoring
241(2)
Suggested Reading
242(1)
89 Diagnosis of Urethral Trauma
243(2)
Suggested Reading
243(2)
90 Management Urethral Trauma
245(2)
Suggested Reading
245(2)
91 Testicular Trauma
247(4)
Suggested Reading
249(2)
92 Testicular Trauma Injury Scale
251(2)
Suggested Reading
251(2)
93 Diagnosis of Testicular Trauma
253(2)
Suggested Reading
253(2)
94 Management of Testicular Trauma
255(2)
Suggested Reading
256(1)
95 Overactive Bladder
257(4)
Suggested Reading
259(2)
96 Diagnosis of Overactive Bladder
261(2)
Suggested Reading
261(2)
97 Management of Overactive Bladder
263(2)
Suggested Reading
263(2)
98 Urinary Incontinence
265(4)
Suggested Reading
267(2)
99 Diagnosis of Incontinence
269(2)
Suggested Reading
269(2)
100 Management of Incontinence
271(2)
Suggested Reading
271(2)
101 Priapism
273(4)
Suggested Reading
275(2)
102 Diagnosis of Priapism
277(2)
Suggested Reading
277(2)
103 Management of Priapism
279(2)
Suggested Reading
279(2)
104 Penile Fracture
281(4)
Suggested Reading
283(2)
105 Diagnosis of Penile Fracture
285(2)
Suggested Reading
286(1)
106 Management of Penile Fracture
287(2)
Suggested Reading
288(1)
107 Phimosis
289(4)
Suggested Reading
291(2)
108 Diagnosis and Management of Phimosis
293(2)
Suggested Reading
293(2)
109 Paraphimosis
295(4)
Suggested Reading
297(2)
110 Management of Paraphimosis
299(2)
Suggested Reading
300(1)
111 Erectile Dysfunction
301(4)
Suggested Reading
303(2)
112 Diagnosis and Management of ED
305(2)
Suggested Reading
305(2)
113 Penile Cancer
307(4)
Suggested Reading
310(1)
114 Diagnosis of Penile Cancer
311(2)
Suggested Reading
311(2)
115 Management of Penile Cancer
313(2)
Suggested Reading
314(1)
116 A Renal Mass
315(6)
Suggested Reading
320(1)
117 Management Pathway for Renal Mass
321(4)
Suggested Reading
323(2)
118 A Painful Scrotum
325(4)
Suggested Reading
327(2)
119 Diagnostic Pathway: A Painful Scrotum
329(2)
Suggested Reading
330(1)
120 Management Pathway: A Painful Scrotum
331(2)
Suggested Reading
331(2)
121 Scrotal Lesions
333(4)
Suggested Reading
335(2)
122 Diagnostic and Management Pathways: Scrotal Lesions
337(2)
Suggested Reading
337(2)
Index 339
Sanchia S. Goonewardene MBChB (Hons.Clin.Sc), BMedSc(Hons), PGCGC, Dip.SSc, MRCS (Ed and Eng). Sanchia Goonewardene qualified from Birmingham Medical School with Honours in Clinical Science. After that she completed her Foundation training at the Royal Centre for Defence Medicine. Her Core General Surgery training was completed in Coventry and Warwickshire. She has worked as Urology Registrar at Guys and St Thomas Hospitals and the Royal Free and UCL and  has over 370 publications to her name. She has significantly contributed to the Urological Academic World with her first two books, Core Surgical Procedures for Urology Trainees and Prostate Cancer Survivorship  -- she has since added a section to EAU on Prostate Cancer Survivorship and Supportive Care, is an associate member of an EAU guidelines panel  and has currently been given her first editorial board position.





David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr. Albala was an endourology fellow at Washington University Medical Center under the direction of Ralph V. Clayman. He practiced at Loyola University Medical Center in Chicago and rose from the ranks of Instructor to full Professor in Urology and Radiology in eight years. After 10 years, he became a tenured Professor at Duke University Medical Center in North Carolina. At Duke, he was Co-Director of the Endourology fellowship and Director for the Center of Minimally Invasive and Robotic Urological Surgery. He has over 150 publications in peer-reviewed journals and has authored three textbooks in endourology and one in general urology. He serves on the editorial board for the Journal of Robotic Surgery, Journal of Endourology, Current Opinions in Urology and Urology Index and Reviews. He serves as a reviewerfor eight surgical journals. At the present time he is Chief of Urology at Crouse Hospital in Syracuse, New York and Medical Director for Associated Medical Professionals. He is considered a national and international authority in laparoscopic and robotic urological surgery and has been an active teacher in this area for over 20 years. His research and clinical interests have focused on robotic urological surgery. In addition, other clinical interests include minimally invasive treatment of benign prostatic hypertrophy (BPH) and the use of fibrin sealants in surgery. He has been a Visiting Professor at numerous institutions across the United States as well as oversea  s in countries such as India, China, Iceland, Germany, France, Japan, Brazil, Australia, and Singapore. In addition, he has done operative demonstrations in over 32 countries and 23 states.